Cargando…

Sudden winter iloprost withdrawal in scleroderma patients during COVID-19 pandemic

INTRODUCTION: Intravenous iloprost is currently recommended in the treatment of Raynaud's phenomenon (RP) refractory to oral therapy and of digital ulcers (DUs) related to systemic sclerosis (SSc). In real-life practice there is a huge heterogeneity about the Iloprost regimens used. METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Lorenzis, Enrico, Natalello, Gerlando, Verardi, Lucrezia, Cerasuolo, Pier Giacomo, Gigante, Laura, D'Agostino, Maria Antonietta, Bosello, Silvia Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271454/ https://www.ncbi.nlm.nih.gov/pubmed/35835174 http://dx.doi.org/10.1016/j.mvr.2022.104404

Ejemplares similares

What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19?
por: De Lorenzis, Enrico, et al.
Publicado: (2020)

Chronic related group classification system as a new public health tool to predict risk and outcome of COVID-19 in patients with systemic rheumatic diseases: A population-based study of more than forty thousand patients
por: De Lorenzis, Enrico, et al.
Publicado: (2023)

Multidisciplinary Evaluation of Interstitial Lung Diseases: New Opportunities Linked to Rheumatologist Involvement
por: De Lorenzis, Enrico, et al.
Publicado: (2020)

Adult-onset Still's disease following COVID-19 vaccination
por: Leone, Flavia, et al.
Publicado: (2021)

Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement()
por: Natalello, Gerlando, et al.
Publicado: (2021)

No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic
por: Alivernini, Stefano, et al.
Publicado: (2020)

Long-term clinical stabilization of scleroderma patients treated with a chronic and intensive IV iloprost regimen
por: Foti, Rosario, et al.
Publicado: (2016)

More to B: the growing evidence to inform targeting B cells in scleroderma
por: Bosello, Silvia Laura, et al.
Publicado: (2022)

Extension of Lung Damage at Chest Computed Tomography in Severely Ill COVID-19 Patients Treated with Interleukin-6 Receptor Blockers Correlates with Inflammatory Cytokines Production and Prognosis
por: Calandriello, Lucio, et al.
Publicado: (2023)

Iloprost Attenuates Oxidative Stress-Dependent Activation of Collagen Synthesis Induced by Sera from Scleroderma Patients in Human Pulmonary Microvascular Endothelial Cells
por: Giordo, Roberta, et al.
Publicado: (2021)

Interleukin-33 and soluble suppression of tumorigenicity 2 in scleroderma cardiac involvement
por: Iannazzo, Francesco, et al.
Publicado: (2022)

Depression and Endothelial Dysfunction in Psoriatic Arthritis: Is There Any Possible Relationship?
por: De Lorenzis, Enrico, et al.
Publicado: (2021)

Hyperbaric Oxygen Therapy with Iloprost Improves Digit Salvage in Severe Frostbite Compared to Iloprost Alone
por: Magnan, Marie-Anne, et al.
Publicado: (2021)

Inhaled iloprost for the control of pulmonary hypertension
por: Krug, Sabine, et al.
Publicado: (2009)

Iloprost for COVID-19-related vasculopathy
por: Moezinia, Carine J, et al.
Publicado: (2020)

Real life use of prostacyclin analog (Iloprost), a multi-centric survey data from the scleroderma study group Emilia Romagna (Sclero-RER) and review of the literature
por: Magnani, Luca, et al.
Publicado: (2023)

Iloprost modulates the immune response in systemic sclerosis
por: D'Amelio, Patrizia, et al.
Publicado: (2010)

Inhaled iloprost for the treatment of patient with Fontan circulation
por: Kim, Yong Hyun, et al.
Publicado: (2014)

Effectiveness of Iloprost in the Treatment of Bone Marrow Edema
por: Tosun, Hacı Bayram, et al.
Publicado: (2020)

Iloprost in COVID-19: The Rationale of Therapeutic Benefit
por: Faggioli, Paola Maria, et al.
Publicado: (2021)

Iloprost for the treatment of frostbite: a scoping review
por: Gauthier, Josianne, et al.
Publicado: (2023)

Scleroderma with Nodular Scleroderma
por: Srisuttiyakorn, Chutika, et al.
Publicado: (2016)

Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression
por: Bosello, Silvia, et al.
Publicado: (2018)

Use of fluorescence to visualize response to iloprost treatment for frostbite
por: MacLennan, Mira, et al.
Publicado: (2021)

Oxidative stress in the pathogenesis of systemic scleroderma: An overview
por: Vona, Rosa, et al.
Publicado: (2018)

Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis
por: Bixio, Riccardo, et al.
Publicado: (2022)

Sudden Caffeine Withdrawal Triggers Migraine—A Randomized Controlled Trial
por: Alstadhaug, Karl B., et al.
Publicado: (2020)

Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs
por: Schermuly, Ralph T, et al.
Publicado: (2007)

Review of inhaled iloprost for the control of pulmonary artery hypertension in children
por: Tissot, Cecile, et al.
Publicado: (2009)

The Effect of Iloprost on Renal Function in Patients with Critical Limb Ischemia()
por: Ay, Yasin, et al.
Publicado: (2013)

User preference for a portable syringe pump for iloprost infusion
por: Laria, Antonella, et al.
Publicado: (2015)

Iloprost requires the Frizzled-9 receptor to prevent lung cancer
por: Sompel, Kayla, et al.
Publicado: (2022)

The Prostacyclin Analogue Iloprost Modulates CXCL10 in Systemic Sclerosis
por: Colasanti, Tania, et al.
Publicado: (2022)

Scleroderma
Publicado: (1890)

Checkpoint Inhibitor-Associated Scleroderma and Scleroderma Mimics
por: Macklin, Michael, et al.
Publicado: (2023)

Autopsy-proven Mirtazapine Withdrawal-induced Mania/Hypomania Associated with Sudden Death
por: Pombo, Rena, et al.
Publicado: (2017)

Use of Inhaled Iloprost in an Infant With Bronchopulmonary Dysplasia and Pulmonary Artery Hypertension
por: Hwang, Seung-Kyung, et al.
Publicado: (2009)

Liposomal nanoparticles encapsulating iloprost exhibit enhanced vasodilation in pulmonary arteries
por: Jain, Pritesh P, et al.
Publicado: (2014)

Effect of iloprost on the microcirculation and liver function after orthotopic liver transplantation
por: Klinzing, S, et al.
Publicado: (2008)

Iloprost as an acute kidney injury-triggering agent in severely atherosclerotic patients
por: Uyar, Mehtap Erkmen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5898gin5tvsnof386g5ncqc8vk